Atlas Trials

The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome

Clinical trial NCT07612592 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07612592
Sponsor
Children's Hospital of Chongqing Medical University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Primary Nephrotic Syndrome
Start date
2026-01-01
Primary completion
2026-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.